Health Care & Life Sciences » Biotechnology | Biofrontera AG

Biofrontera AG | Income Statement

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
3,114.60
3,095.60
4,137.90
6,130.30
12,025.00
21,107
Cost of Goods Sold (COGS) incl. D&A
2,345.80
1,923.70
2,039.50
2,474.20
2,457.00
5,190
Gross Income
768.70
1,171.90
2,098.40
3,656.00
9,568.00
15,917
SG&A Expense
7,906.50
9,829.10
12,064.40
14,608.70
22,919.00
33,899
EBIT
7,137.70
8,657.20
9,966.00
10,952.70
13,351.00
17,982
Unusual Expense
815.00
-
-
-
-
-
Non Operating Income/Expense
473.90
94.70
186.90
2,403.60
1,073.00
969
Interest Expense
1,270.00
2,159.30
1,433.50
2,033.10
1,716.00
2,280
Pretax Income
8,066.60
10,721.00
11,203.40
10,579.20
16,102.00
19,269
Consolidated Net Income
8,066.60
10,721.00
11,203.40
10,579.20
16,102.00
8,878
Net Income
8,066.60
10,721.00
11,203.40
10,579.20
16,102.00
8,878
Net Income After Extraordinaries
8,066.60
10,721.00
11,203.40
10,579.20
16,102.00
8,878
Net Income Available to Common
8,066.60
10,721.00
11,203.40
10,579.20
16,102.00
8,878
EPS (Basic)
0.43
0.45
0.45
0.34
0.40
0.20
Basic Shares Outstanding
18,849.60
23,648.00
24,582.70
31,219.70
39,967.00
43,695.80
EPS (Diluted)
0.43
0.45
0.46
0.34
0.40
0.20
Diluted Shares Outstanding
18,849.60
23,648.00
24,582.70
31,219.70
39,967.00
43,695.80
EBITDA
6,395.60
7,846.20
9,154.40
10,121.90
12,467.00
17,228
Non-Operating Interest Income
-
190.30
9.20
2.90
38.00
24

About Biofrontera

View Profile
Address
Hemmelrather Weg 201
Leverkusen Nordrhein-Westfalen 51377
Germany
Employees -
Website http://biofrontera.com
Updated 07/08/2019
Biofrontera AG is a biopharmaceutical company, which engages in the development, sale, and distribution of dermatological drugs and medical cosmetics for the care, protection, and treatment of the skin. Its products are used for the treatment of chronic, antihistamine refractory urticaria, and migraine prophylaxis. The company was founded by Hermann Lübbert in 1997 and is headquartered in Leverkusen, Germany.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.